We are live on ! Find out more
BPCE

Bank Pictet & Cie (Europe) Portfolio holdings

AUM $5.12B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-4.1%
1 Year Est. Return
+27.39%
3 Year Est. Return
+99.4%
5 Year Est. Return
+123.97%
10 Year Est. Return
+508.14%
AUM
$4.19B
AUM Growth
-$365M
Cap. Flow
-$116M
Cap. Flow %
-2.77%
Top 10 Hldgs %
46.9%
Holding
204
New
38
Increased
55
Reduced
66
Closed
18

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$40.9M
2
ABBV icon
AbbVie
ABBV
+$15.3M
3
ETN icon
Eaton
ETN
+$14.9M
4
PG icon
Procter & Gamble
PG
+$9.77M
5
MRSH
Marsh
MRSH
+$8.31M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$40.7M
2
PEP icon
PepsiCo
PEP
+$33.5M
3
AMZN icon
Amazon
AMZN
+$21.9M
4
V icon
Visa
V
+$15.9M
5
MSFT icon
Microsoft
MSFT
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 16.78%
3 Financials 16.25%
4 Consumer Discretionary 15.23%
5 Communication Services 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEN icon
201
Penumbra
PEN
$12.9B
– –
-1,092
Closed -$259K
PFE icon
202
Pfizer
PFE
$150B
– –
-10,100
Closed -$268K
SRPT icon
203
Sarepta Therapeutics
SRPT
$1.94B
– –
-2,467
Closed -$300K
XBI icon
204
State Street SPDR S&P Biotech ETF
XBI
$10.5B
– –
-9,110
Closed -$820K
5 6 7 8
9

Similar funds

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s Q1 2025 Portfolio in Review

As of Q1 2025, Bank Pictet & Cie (Europe) held 204 positions worth $4.19B, down 8% from $4.56B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Bank Pictet & Cie (Europe)'s Q1 2025 filing shows 38 new, 55 increased, 66 reduced and 18 closed positions. Its largest new stake was ASE Group: 133,517 shares worth $1.17M. The largest sale was Thermo Fisher Scientific, an estimated $40.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Bank Pictet & Cie (Europe)'s largest Q1 2025 buy was ASE Group: 133,517 shares worth $1.17M.
  • Bank Pictet & Cie (Europe) added most to Stryker in Q1 2025, an estimated $40.9M increase.
  • Bank Pictet & Cie (Europe)'s biggest Q1 2025 reduction was Thermo Fisher Scientific, cutting an estimated $40.7M.
  • Bank Pictet & Cie (Europe) fully exited Marvell Technology in Q1 2025, selling an estimated $7.37M.
  • Bank Pictet & Cie (Europe)'s ten largest holdings make up 47% of its $4.19B portfolio in Q1 2025.
  • Bank Pictet & Cie (Europe) opened 38 new positions and closed 18 in Q1 2025.
  • Bank Pictet & Cie (Europe)'s portfolio value fell 8% quarter-over-quarter to $4.19B.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2025, filed 17 Apr 2025.